This is the second SOD application center that Merck has established in Asia to meet the region’s high demand.

Germany-based Merck KGaA has announced the launch of a new €290m ($317.6m) biosafety testing facility in Rockville, Maryland, ...

Jefferies analyst Brian Balchin maintained a Buy rating on Merck KGaA (0O14 – Research Report) today and set a price target of €180.00.

Merck & Co. hopes a new positive trial readout can return Keytruda to glory in head and neck cancer. | Merck & Co. hopes a ...

Exelixis, an Alameda, Calif., oncology company, and Rahway, N.J., drugmaker Merck said they also plan a Phase 1/2 trial and two Phase 3 studies of zanzalintinib in combination with Merck's Welireg in ...

MilliporeSigma, the U.S. and Canada life sciences arm of Germany’s Merck KGaA, is unveiling a new Rockville hub to both consolidate its local footprint and continue to grow its headcount.

Merck opened its latest spin-on-dielectric (SOD) application center in Anseong, Gyeonggi Province, on Thursday as part of the ...

Merck is immune from an antitrust lawsuit accusing it of misleading regulators about the effectiveness of its mumps vaccine ...

A Merck & Co. Inc. diverse leadership program unlawfully excludes White and Asian workers, according to an EEOC charge filed ...

Merck's recent decline is due to reduced profit guidance and FDA decisions, but shares are at a support level. Read why I ...

Summit Therapeutics has a pipeline candidate that could be more effective than Merck's Keytruda. It's a good start, but ...

Technical indicators and charts suggest high risk for Merck, with the stock repeatedly breaking down. See why I rate MRK ...